1. What Is the Proteomics Market?
The Proteomics Market covers analytical platforms, reagents, and bioinformatics enabling large-scale identification, quantification, and characterisation of protein expression, modification, and interaction in biological samples for biomarker discovery and drug development. Proteomics encompasses mass spectrometry, protein array, flow cytometry, protein interaction study, and proteomic bioinformatics. Market dynamics reflect mass spectrometry sensitivity enabling plasma proteome at deep coverage, proximity extension assay enabling 5,000-protein plasma measurement, and AI proteomics accelerating protein structure-based drug design.
2. Proteomics Market Size & Forecast
3. Emerging Technologies
- AI protein structure prediction enabling proteome-wide drug binding site identification are advancing. Growing adoption in drug discovery is driven by novel target identification from computationally predicted protein structure.
- Plasma proteomics biomarker panel predicting cancer, cardiovascular, and neurodegeneration risk are advancing. Growing clinical adoption is driven by multi-disease early detection from single blood draw.
- Phosphoproteomics mapping signalling pathway activation from kinase substrate phosphorylation are advancing. Growing adoption in drug development is driven by mechanism-of-action biomarker and target validation requirements.
- Single-cell proteomics achieving protein quantification from individual cell without amplification are advancing. Growing adoption is driven by cell heterogeneity protein characterisation research requirements.
Comparable technologies are influencing adjacent market segments in similar ways. Read more in our Spatial Biology Market.
4. Key Market Opportunity
The largest addressable opportunity within the Proteomics Market is the clinical biomarker discovery sub-market, where plasma proteomics panel creates diagnostics and drug response biomarker investment. Drug development proteomics creates a pharma research opportunity as protein biomarker and target validation drives CRO and platform subscription. AI-enabled protein structure drug design creates a computational drug discovery opportunity as AlphaFold enables proteome-wide target identification. Asia Pacific proteomics creates geographic expansion as Chinese, Japanese, and South Korean academic and biotech proteomics investment grows.
5. Top Companies in the Proteomics Market
The following organisations hold leading positions in the Proteomics Market. The full report provides revenue share, SWOT analysis, and competitive benchmarking for each player.
- Thermo Fisher (Orbitrap)
- Waters (Xevo MS)
- Olink Proteomics (PEA)
- SomaLogic (SomaScan)
- Bruker (timsTOF)
- SCIEX (ZenoTOF)
- Agilent (Q-TOF)
- Luminex (Multiplex)
- Meso Scale Discovery (MSD)
- Bio-Rad (Protein Array)
6. Market Segmentation
The Proteomics Market is analysed across 3 segmentation dimensions. Revenue data, growth rates, and competitive intensity by sub-segment are available in the full report.
| Segmentation | Sub-Segments |
|---|---|
| By Platform | Mass Spectrometry Protein Array Flow Cytometry Proximity Extension Protein Interaction |
| By Application | Biomarker Discovery Drug Development Clinical Diagnostics Food Safety Agriculture |
| By Geography | North America Europe Asia Pacific Latin America Middle East and Africa |
7. Key Market Trends (2026–2034)
Three major forces are shaping the Proteomics Market trajectory over the forecast period:
Thermo Fisher and Waters Achieve Combined 45 Percent Global Proteomics Mass Spectrometry Share.Thermo Fisher Orbitrap Eclipse and Waters Xevo mass spectrometer achieving combined 45 percent global proteomics mass spectrometry market share in 2024 demonstrate analytical instrument company commercial dominance. Thermo Fisher Orbitrap achieving 100,000 resolution at 400 m/z demonstrates the resolution enabling protein isoform and modification identification.
Olink Proteomics Achieves Proximity Extension Assay Leadership for 5,000-Protein Plasma Measurement.Olink Proteomics achieving 5,000-protein simultaneous plasma measurement using proximity extension assay in 2024 demonstrates multiplexed protein biomarker quantification at commercial biomarker discovery scale. Olink Explore 3072 achieving 3,072 protein simultaneous measurement demonstrates the panel breadth enabling population-scale biomarker discovery.
SomaLogic Achieves 7,000-Protein Aptamer-Based Plasma Proteomics at Clinical Cohort Scale.SomaLogic SomaScan achieving 7,000-protein simultaneous measurement at clinical cohort scale in 2024 demonstrates aptamer-based proteomics at the largest multiplexed protein platform breadth. SomaScan UK Biobank deployment measuring 50,000 plasma samples demonstrates population proteomics at public health research scale.
For related market intelligence, see the Digital Pathology Market.
8. Segmental Analysis
By platform, the Mass Spectrometry segment dominated the Proteomics Market in 2025. Representing the largest revenue category as Thermo Fisher and Waters instrument and consumable drives the majority of proteomics market value. The Multiplexed Protein Biomarker Panel segment is the fastest-growing category, advancing as Olink and SomaLogic proximity assay achieves clinical research adoption at population scale.
By application, Drug Development dominated in 2025, while Clinical Diagnostics is registering the highest proteomics platform adoption growth rate.
9. Regional Analysis
Regional demand patterns across the Proteomics Market reflect differences in regulation, technological maturity, and capital investment.
Largest Market Share
North America accounted for the largest share of the Proteomics Market in 2025, holding 46.6% of the global market. Biopharmaceutical companies, academic research institutions, and clinical proteomics organisations are deploying proteomics platforms for drug target identification, biomarker discovery, and protein characterisation in precision medicine and drug development applications. NIH investment in proteomics infrastructure and growing pharmaceutical interest in protein-level biomarkers for companion diagnostic development are encouraging platform adoption. High life sciences research investment, established mass spectrometry infrastructure, and strong pharmaceutical demand for proteomics data are generating regional demand.
Highest CAGR Region
Europe is expected to register the highest CAGR of 15.01% during the forecast period. Pharmaceutical companies, academic research institutions, and life sciences technology organisations across Germany, the United Kingdom, Switzerland, Sweden, and the Netherlands are deploying proteomics platforms for drug discovery, clinical biomarker research, and personalised medicine development. European research funding and growing pharmaceutical investment in protein biomarker identification for targeted therapy development are encouraging proteomics adoption. Rising clinical proteomics research activity and increasing adoption of mass spectrometry-based protein analysis are generating European demand.
10. Full Report with Exclusive Insights
The complete published market report includes an in-depth analysis of market dynamics, industry trends, competitive landscape, regional outlook, and future growth opportunities. The study provides detailed market sizing and forecasts across key segments and geographies, along with comprehensive insights into drivers, restraints, opportunities, challenges, technological advancements, regulatory landscape, and evolving consumer and industry trends. The report also features company profiles, strategic developments, market share analysis, and actionable recommendations to support informed business decision-making. Additionally, the syndicated report package typically includes forecast datasets, charts and figures, research methodology, and analyst support for strategic interpretation and planning.
Advanced Strategic & Custom Intelligence
In addition to the standard syndicated report package, TrendX Insights can provide the following advanced strategic analyses and customized intelligence solutions for any market:
Standard Report Coverage
- • Competitor Analysis
- • Country Trade Analysis
- • Import & Export Analysis
- • Porter’s Five Forces Analysis
- • SWOT Analysis by Companies
- • TrendX Insights Quadrant Positioning
- • Pricing Analysis
- • Detailed Macro-Economic Indicators Assessment
- • List of Raw Material Suppliers
- • Regulatory Framework Assessment
- • Supply Chain Resilience Mapping
- • Value Chain Analysis
- • Technology adoption trends and innovation tracking
- • Custom company profiling and benchmarking
Exclusive Sections With Additional Cost
- • Agentic AI Readiness Score
- • TAM, SAM, and SOM Analysis
- • AI Act & Privacy Compliance Audit
- • Channel Partner Ecosystem Mapping
- • China + 1 Strategy Analysis
- • Circular Economy Opportunities Assessment
- • Competitor Benchmarking KPI Analysis
- • Country Trade Analysis
- • Country-level opportunity mapping
- • Digital Maturity Matrix
- • Ecosystem Interdependency Mapping
- • ESG & Decarbonization Roadmap
- • Geopolitical Friction Scorecard
- • Geopolitical Risk Assessment
- • Humanoid Workforce Impact Analysis
- • Investment Heatmap
- • List of Distributors and Channel Partners
- • List of Raw Material Suppliers
- • Market Entry Strategy Assessment
- • Mergers & Acquisitions (M&A) Analysis
- • Patent & Intellectual Property (IP) Analysis
- • Pilot Project Analysis
- • Potential High-Growth Region/Country Investment Assessment
- • Product Comparison Analysis
- • Product Revenue Analysis
- • R&D Investment Analysis in Emerging Technologies
- • Raw Material Scarcity Forecast
Note: For highly customized requirements, deeper strategic assessments, company-specific intelligence, or tailored consulting support, please contact TrendX Insights.
Full Report with Exclusive Insights
Available to clients on request
Explore Our Published Reports Library
This page covers market-level data estimates. For comprehensive published research reports including full methodology, primary data, and detailed company profiles, browse the TrendX Insights Published Reports Library.
Visit Published Reports Library ›11. Related Market Reports
Frequently Asked Questions
The Proteomics Market was valued at USD 28.04 Bn in 2025 and is projected to reach USD 75.91 Bn by 2034, growing at a CAGR of 11.7% over the 2026–2034 forecast period.
The Proteomics Market is projected to grow at a CAGR of 11.7% from 2026 to 2034.
North America accounted for the largest share of the Proteomics Market in 2025, holding 46.6% of the global market.
The leading companies in the Proteomics Market include Thermo Fisher (Orbitrap), Waters (Xevo MS), Olink Proteomics (PEA), SomaLogic (SomaScan), Bruker (timsTOF), SCIEX (ZenoTOF), Agilent (Q-TOF), Luminex (Multiplex), Meso Scale Discovery (MSD), Bio-Rad (Protein Array).
Thermo fisher and waters achieve combined 45 percent global proteomics mass spectrometry share.
By platform, the Mass Spectrometry segment dominated the Proteomics Market in 2025.
How to Order
Purchasing a TrendX Insights report is straightforward. Our process is designed to be transparent and risk-free for buyers, with a 20% upfront model and full delivery before the balance payment.
This is the price of the syndicated report. Any custom inclusions beyond the Table of Contents will be scoped and priced separately. For the full list of what is covered in the syndicated report, refer to the Table of Contents tab.
A curated, condensed version of this report for students, researchers, and academic institutions. Ideal for thesis work, dissertations, and academic projects. Delivered as PDF to your institutional email.
Valid student ID or institutional email required. For educational and non-commercial use only.